• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定和免疫鉴定非酒精性脂肪性肝病中与脂质代谢相关的分子簇。

Identification and immunological characterization of lipid metabolism-related molecular clusters in nonalcoholic fatty liver disease.

机构信息

Department of General Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China.

Laboratory of Integrative Medicine, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China.

出版信息

Lipids Health Dis. 2023 Aug 9;22(1):124. doi: 10.1186/s12944-023-01878-0.

DOI:10.1186/s12944-023-01878-0
PMID:37559129
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10410946/
Abstract

BACKGROUND

Nonalcoholic fatty liver disease (NAFLD) is now the major contributor to chronic liver disease. Disorders of lipid metabolism are a major element in the emergence of NAFLD. This research intended to explore lipid metabolism-related clusters in NAFLD and establish a prediction biomarker.

METHODS

The expression mode of lipid metabolism-related genes (LMRGs) and immune characteristics in NAFLD were examined. The "ConsensusClusterPlus" package was utilized to investigate the lipid metabolism-related subgroup. The WGCNA was utilized to determine hub genes and perform functional enrichment analysis. After that, a model was constructed by machine learning techniques. To validate the predictive effectiveness, receiver operating characteristic curves, nomograms, decision curve analysis (DCA), and test sets were used. Lastly, gene set variation analysis (GSVA) was utilized to investigate the biological role of biomarkers in NAFLD.

RESULTS

Dysregulated LMRGs and immunological responses were identified between NAFLD and normal samples. Two LMRG-related clusters were identified in NAFLD. Immune infiltration analysis revealed that C2 had much more immune infiltration. GSVA also showed that these two subtypes have distinctly different biological features. Thirty cluster-specific genes were identified by two WGCNAs. Functional enrichment analysis indicated that cluster-specific genes are primarily engaged in adipogenesis, signalling by interleukins, and the JAK-STAT signalling pathway. Comparing several models, the random forest model exhibited good discrimination performance. Importantly, the final five-gene random forest model showed excellent predictive power in two test sets. In addition, the nomogram and DCA confirmed the precision of the model for NAFLD prediction. GSVA revealed that model genes were down-regulated in several immune and inflammatory-related routes. This suggests that these genes may inhibit the progression of NAFLD by inhibiting these pathways.

CONCLUSIONS

This research thoroughly emphasized the complex relationship between LMRGs and NAFLD and established a five-gene biomarker to evaluate the risk of the lipid metabolism phenotype and the pathologic results of NAFLD.

摘要

背景

非酒精性脂肪性肝病(NAFLD)现已成为慢性肝病的主要病因。脂代谢紊乱是非酒精性脂肪性肝病发生的重要因素。本研究旨在探讨 NAFLD 中与脂代谢相关的聚类,并建立预测生物标志物。

方法

检测 NAFLD 中脂代谢相关基因(LMRGs)的表达模式和免疫特征。利用“ConsensusClusterPlus”包对脂代谢相关亚群进行研究。利用 WGCNA 确定枢纽基因并进行功能富集分析。然后,通过机器学习技术构建模型。为了验证预测的有效性,使用了接收器工作特征曲线、列线图、决策曲线分析(DCA)和测试集。最后,利用基因集变异分析(GSVA)研究生物标志物在 NAFLD 中的生物学作用。

结果

在 NAFLD 和正常样本之间鉴定出失调的 LMRGs 和免疫反应。在 NAFLD 中确定了两个 LMRG 相关的聚类。免疫浸润分析表明 C2 具有更多的免疫浸润。GSVA 还表明这两种亚型具有明显不同的生物学特征。通过两个 WGCNAs 确定了 30 个聚类特异性基因。功能富集分析表明,聚类特异性基因主要参与脂肪生成、白细胞介素信号和 JAK-STAT 信号通路。比较几种模型,随机森林模型表现出良好的判别性能。重要的是,最终的五个基因随机森林模型在两个测试集中表现出优异的预测能力。此外,列线图和 DCA 证实了模型对 NAFLD 预测的准确性。GSVA 显示模型基因在几个免疫和炎症相关途径中下调。这表明这些基因可能通过抑制这些途径来抑制 NAFLD 的进展。

结论

本研究深入强调了 LMRGs 与 NAFLD 之间的复杂关系,并建立了一个五基因生物标志物来评估脂代谢表型和 NAFLD 病理结果的风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ea0/10410946/738aed90139b/12944_2023_1878_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ea0/10410946/d3ffea3a745c/12944_2023_1878_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ea0/10410946/dbd8ced2972c/12944_2023_1878_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ea0/10410946/2bc91fb02081/12944_2023_1878_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ea0/10410946/ede0507f7f6f/12944_2023_1878_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ea0/10410946/6f21b3e591bc/12944_2023_1878_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ea0/10410946/07caaeede205/12944_2023_1878_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ea0/10410946/ad81ba565371/12944_2023_1878_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ea0/10410946/738aed90139b/12944_2023_1878_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ea0/10410946/d3ffea3a745c/12944_2023_1878_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ea0/10410946/dbd8ced2972c/12944_2023_1878_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ea0/10410946/2bc91fb02081/12944_2023_1878_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ea0/10410946/ede0507f7f6f/12944_2023_1878_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ea0/10410946/6f21b3e591bc/12944_2023_1878_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ea0/10410946/07caaeede205/12944_2023_1878_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ea0/10410946/ad81ba565371/12944_2023_1878_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ea0/10410946/738aed90139b/12944_2023_1878_Fig8_HTML.jpg

相似文献

1
Identification and immunological characterization of lipid metabolism-related molecular clusters in nonalcoholic fatty liver disease.鉴定和免疫鉴定非酒精性脂肪性肝病中与脂质代谢相关的分子簇。
Lipids Health Dis. 2023 Aug 9;22(1):124. doi: 10.1186/s12944-023-01878-0.
2
Identification of novel biomarkers based on lipid metabolism-related molecular subtypes for moderately severe and severe acute pancreatitis.基于脂质代谢相关分子亚型的中度重症和重症急性胰腺炎新型生物标志物的鉴定。
Lipids Health Dis. 2024 Jan 2;23(1):1. doi: 10.1186/s12944-023-01972-3.
3
Identification and validation of disulfidptosis-associated molecular clusters in non-alcoholic fatty liver disease.非酒精性脂肪性肝病中与二硫化物诱导性细胞死亡相关分子簇的鉴定与验证
Front Genet. 2023 Sep 8;14:1251999. doi: 10.3389/fgene.2023.1251999. eCollection 2023.
4
Identification of lipid metabolism-related biomarkers for diagnosis and molecular classification of atherosclerosis.鉴定脂质代谢相关生物标志物,用于动脉粥样硬化的诊断和分子分型。
Lipids Health Dis. 2023 Jul 6;22(1):96. doi: 10.1186/s12944-023-01864-6.
5
Identification and validation of cuproptosis-related molecular clusters in non-alcoholic fatty liver disease.鉴定和验证非酒精性脂肪性肝病中与铜死亡相关的分子簇。
J Cell Mol Med. 2024 Feb;28(3):e18091. doi: 10.1111/jcmm.18091. Epub 2024 Jan 3.
6
Identification of common signature genes and pathways underlying the pathogenesis association between nonalcoholic fatty liver disease and atherosclerosis.非酒精性脂肪性肝病与动脉粥样硬化发病机制关联中共同特征基因和通路的鉴定
Front Cardiovasc Med. 2023 Mar 30;10:1142296. doi: 10.3389/fcvm.2023.1142296. eCollection 2023.
7
Identification and validation of potential diagnostic signature and immune cell infiltration for NAFLD based on cuproptosis-related genes by bioinformatics analysis and machine learning.基于铜死亡相关基因的生物信息学分析和机器学习鉴定和验证非酒精性脂肪性肝病的潜在诊断标志物和免疫细胞浸润。
Front Immunol. 2023 Sep 26;14:1251750. doi: 10.3389/fimmu.2023.1251750. eCollection 2023.
8
Integrative analysis identifies oxidative stress biomarkers in non-alcoholic fatty liver disease via machine learning and weighted gene co-expression network analysis.基于机器学习和加权基因共表达网络分析的整合分析确定非酒精性脂肪性肝病的氧化应激生物标志物。
Front Immunol. 2024 Feb 27;15:1335112. doi: 10.3389/fimmu.2024.1335112. eCollection 2024.
9
Identification of biomarkers for the diagnosis of chronic kidney disease (CKD) with non-alcoholic fatty liver disease (NAFLD) by bioinformatics analysis and machine learning.基于生物信息学分析和机器学习的非酒精性脂肪性肝病(NAFLD)合并慢性肾脏病(CKD)诊断生物标志物的鉴定。
Front Endocrinol (Lausanne). 2023 Feb 27;14:1125829. doi: 10.3389/fendo.2023.1125829. eCollection 2023.
10
Unveiling the mitophagy puzzle in non-alcoholic fatty liver disease (NAFLD): Six hub genes for early diagnosis and immune modulatory roles.揭开非酒精性脂肪性肝病(NAFLD)中的线粒体自噬之谜:用于早期诊断和免疫调节作用的六个关键基因
Heliyon. 2024 Mar 31;10(7):e28935. doi: 10.1016/j.heliyon.2024.e28935. eCollection 2024 Apr 15.

引用本文的文献

1
Molecular Subtypes and Biomarkers of Ulcerative Colitis Revealed by Sphingolipid Metabolism-Related Genes: Insights from Machine Learning and Molecular Dynamics.鞘脂代谢相关基因揭示的溃疡性结肠炎分子亚型和生物标志物:来自机器学习和分子动力学的见解
Curr Issues Mol Biol. 2025 Aug 4;47(8):616. doi: 10.3390/cimb47080616.
2
Schematic Assessment of Metabolic Signatures of Non-alcoholic Fatty Liver Disease by Bridging Endocrinology and Internal Medicine: A Precision Therapy-Based Meta-Analysis.通过内分泌学与内科相结合对非酒精性脂肪性肝病代谢特征进行的示意图评估:一项基于精准治疗的荟萃分析
Cureus. 2025 Apr 28;17(4):e83133. doi: 10.7759/cureus.83133. eCollection 2025 Apr.
3

本文引用的文献

1
Hepatic inflammatory responses in liver fibrosis.肝纤维化中的肝脏炎症反应。
Nat Rev Gastroenterol Hepatol. 2023 Oct;20(10):633-646. doi: 10.1038/s41575-023-00807-x. Epub 2023 Jul 3.
2
Mettl3-mediated mA modification plays a role in lipid metabolism disorders and progressive liver damage in mice by regulating lipid metabolism-related gene expression.Mettl3 介导的 mA 修饰通过调节脂质代谢相关基因的表达在小鼠的脂质代谢紊乱和进行性肝损伤中发挥作用。
Aging (Albany NY). 2023 Jun 16;15(12):5550-5568. doi: 10.18632/aging.204810.
3
The combined signatures of the tumour microenvironment and nucleotide metabolism-related genes provide a prognostic and therapeutic biomarker for gastric cancer.
Exploring the pathogenesis, biomarkers, and potential drugs for type 2 diabetes mellitus and acute pancreatitis through a comprehensive bioinformatic analysis.
通过全面的生物信息学分析探索2型糖尿病和急性胰腺炎的发病机制、生物标志物及潜在药物。
Front Endocrinol (Lausanne). 2024 Nov 20;15:1405726. doi: 10.3389/fendo.2024.1405726. eCollection 2024.
4
Identification of novel biomarkers based on lipid metabolism-related molecular subtypes for moderately severe and severe acute pancreatitis.基于脂质代谢相关分子亚型的中度重症和重症急性胰腺炎新型生物标志物的鉴定。
Lipids Health Dis. 2024 Jan 2;23(1):1. doi: 10.1186/s12944-023-01972-3.
5
Identification of the methotrexate resistance-related diagnostic markers in osteosarcoma via adaptive total variation netNMF and multi-omics datasets.通过自适应全变差netNMF和多组学数据集鉴定骨肉瘤中与甲氨蝶呤耐药相关的诊断标志物
Front Genet. 2023 Oct 23;14:1288073. doi: 10.3389/fgene.2023.1288073. eCollection 2023.
肿瘤微环境和核苷酸代谢相关基因的联合特征可为胃癌提供预后和治疗的生物标志物。
Sci Rep. 2023 Apr 24;13(1):6622. doi: 10.1038/s41598-023-33213-z.
4
Integrating single-cell analysis and machine learning to create glycosylation-based gene signature for prognostic prediction of uveal melanoma.将单细胞分析和机器学习相结合,创建基于糖基化的基因标志物,用于葡萄膜黑色素瘤的预后预测。
Front Endocrinol (Lausanne). 2023 Mar 23;14:1163046. doi: 10.3389/fendo.2023.1163046. eCollection 2023.
5
Single-cell sequencing and bulk RNA sequencing reveal a cell differentiation-related multigene panel to predict the prognosis and immunotherapy response of hepatocellular carcinoma.单细胞测序和批量RNA测序揭示了一个与细胞分化相关的多基因面板,以预测肝细胞癌的预后和免疫治疗反应。
Chin Med J (Engl). 2023 Feb 20;136(4):485-487. doi: 10.1097/CM9.0000000000002393.
6
Comprehensive characterization of extracellular matrix-related genes in PAAD identified a novel prognostic panel related to clinical outcomes and immune microenvironment: A silico analysis with and vitro validation.采用 与 体外验证的计算分析方法,全面鉴定了 PAAD 细胞外基质相关基因,确定了一个与临床结局和免疫微环境相关的新预后标志物。
Front Immunol. 2022 Oct 13;13:985911. doi: 10.3389/fimmu.2022.985911. eCollection 2022.
7
Machine learning identification of cuproptosis and necroptosis-associated molecular subtypes to aid in prognosis assessment and immunotherapy response prediction in low-grade glioma.基于机器学习的铜死亡和坏死性凋亡相关分子亚型鉴定,以辅助低级别胶质瘤的预后评估和免疫治疗反应预测。
Front Genet. 2022 Sep 12;13:951239. doi: 10.3389/fgene.2022.951239. eCollection 2022.
8
Molecular mechanisms of metabolic associated fatty liver disease (MAFLD): functional analysis of lipid metabolism pathways.代谢相关性脂肪性肝病(MAFLD)的分子机制:脂质代谢途径的功能分析。
Clin Sci (Lond). 2022 Sep 30;136(18):1347-1366. doi: 10.1042/CS20220572.
9
Identification of the Non-Alcoholic Fatty Liver Disease Molecular Subtypes Associated With Clinical and Immunological Features Bioinformatics Methods.非酒精性脂肪性肝病分子亚型与临床和免疫学特征的鉴定 生物信息学方法。
Front Immunol. 2022 Jul 25;13:857892. doi: 10.3389/fimmu.2022.857892. eCollection 2022.
10
New dawn for cancer cell death: Emerging role of lipid metabolism.癌症细胞死亡的新曙光:脂质代谢的新兴作用。
Mol Metab. 2022 Sep;63:101529. doi: 10.1016/j.molmet.2022.101529. Epub 2022 Jun 15.